-
2
-
-
69249104612
-
The 2008 World Health Organization classification system for myeloproliferative neoplasms: Order out of chaos
-
Tefferi A, Thiele J, Vardiman JW. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer 2009; 115: 3842-3847.
-
(2009)
Cancer
, vol.115
, pp. 3842-3847
-
-
Tefferi, A.1
Thiele, J.2
Vardiman, J.W.3
-
3
-
-
0015694748
-
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
-
Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-293.
-
(1973)
Nature
, vol.243
, pp. 290-293
-
-
Rowley, J.D.1
-
4
-
-
77957088676
-
Stem cell transplant for chronic myeloid leukemia in the imatinib era [review]
-
Radich J. Stem cell transplant for chronic myeloid leukemia in the imatinib era [review]. Semin Hematol 2010; 47: 354-361.
-
(2010)
Semin Hematol
, vol.47
, pp. 354-361
-
-
Radich, J.1
-
5
-
-
34249664406
-
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
-
Hehlmann R, Berger U, Pfirrmann M, Heimpel H, Hochhaus A, Hasford J et al. Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Blood 2007; 109: 4686-4692.
-
(2007)
Blood
, vol.109
, pp. 4686-4692
-
-
Hehlmann, R.1
Berger, U.2
Pfirrmann, M.3
Heimpel, H.4
Hochhaus, A.5
Hasford, J.6
-
6
-
-
77949767505
-
International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib
-
Deininger M, O'Brien SG, Guilhot F, Goldman JM, Hochhaus A, Hughes TP et al. International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib. ASH Annu Meet Abstr 2009; 114: 1126.
-
(2009)
ASH Annu Meet Abstr
, vol.114
, pp. 1126
-
-
Deininger, M.1
O'Brien, S.G.2
Guilhot, F.3
Goldman, J.M.4
Hochhaus, A.5
Hughes, T.P.6
-
7
-
-
0032480589
-
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
-
Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 1998; 352: 1087-1092.
-
(1998)
Lancet
, vol.352
, pp. 1087-1092
-
-
Gratwohl, A.1
Hermans, J.2
Goldman, J.M.3
Arcese, W.4
Carreras, E.5
Devergie, A.6
-
8
-
-
33646017748
-
Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: Transplant activity, long-term data and current results An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
-
Gratwohl A, Brand R, Apperley J, Crawley C, Ruutu T, Corradini P et al. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2006; 91: 513-521.
-
(2006)
Haematologica
, vol.91
, pp. 513-521
-
-
Gratwohl, A.1
Brand, R.2
Apperley, J.3
Crawley, C.4
Ruutu, T.5
Corradini, P.6
-
9
-
-
70350341896
-
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia - A report from the German Registry covering the period from 1998 to 2004
-
Bacher U, Klyuchnikov E, Zabelina T, Ottinger H, Beelen DW, Schrezenmeier H et al. The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia - a report from the German Registry covering the period from 1998 to 2004. Ann Hematol 2009; 88: 1237-1247.
-
(2009)
Ann Hematol
, vol.88
, pp. 1237-1247
-
-
Bacher, U.1
Klyuchnikov, E.2
Zabelina, T.3
Ottinger, H.4
Beelen, D.W.5
Schrezenmeier, H.6
-
10
-
-
34247863611
-
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia
-
Giralt SA, Arora M, Goldman JM, Lee SJ, Maziarz RT, McCarthy PL et al. Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia. Br J Haematol 2007; 137: 461-467.
-
(2007)
Br J Haematol
, vol.137
, pp. 461-467
-
-
Giralt, S.A.1
Arora, M.2
Goldman, J.M.3
Lee, S.J.4
Maziarz, R.T.5
McCarthy, P.L.6
-
11
-
-
54049146732
-
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia
-
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M et al. Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. Blood 2008; 112: 3500-3507.
-
(2008)
Blood
, vol.112
, pp. 3500-3507
-
-
Lee, S.J.1
Kukreja, M.2
Wang, T.3
Giralt, S.A.4
Szer, J.5
Arora, M.6
-
12
-
-
77950391550
-
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: Evaluation of its impact within a subgroup of the randomized German CML Study IV
-
Saussele S, Lauseker M, Gratwohl A, Beelen DW, Bunjes D, Schwerdtfeger R et al. Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV. Blood 2010; 115: 1880-1885.
-
(2010)
Blood
, vol.115
, pp. 1880-1885
-
-
Saussele, S.1
Lauseker, M.2
Gratwohl, A.3
Beelen, D.W.4
Bunjes, D.5
Schwerdtfeger, R.6
-
13
-
-
0035800507
-
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
-
Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876-880.
-
(2001)
Science
, vol.293
, pp. 876-880
-
-
Gorre, M.E.1
Mohammed, M.2
Ellwood, K.3
Hsu, N.4
Paquette, R.5
Rao, P.N.6
-
14
-
-
79953689908
-
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations
-
Jabbour E, Cortes J, Santos FPS, Jones D, O'Brien S, Rondon G et al. Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations. Blood 2011; 117: 3641-3647.
-
(2011)
Blood
, vol.117
, pp. 3641-3647
-
-
Jabbour, E.1
Cortes, J.2
Santos, F.P.S.3
Jones, D.4
O'Brien, S.5
Rondon, G.6
-
15
-
-
84860841611
-
Initial findings from the PACE Trial: A pivotal phase. 2. Study of Ponatinib in patients with CML and Ph+ ALL resistant or intolerant to dasatinib or nilotinib, or with the T315I mutation
-
Cortes JE, Kim D-W, Pinilla-Ibarz J, Le Coutre PD, Chuah C, Nicolini FE et al. Initial findings from the PACE Trial: a pivotal phase. 2. study of Ponatinib in patients with CML and Ph+ ALL resistant or intolerant to dasatinib or nilotinib, or with the T315I mutation. ASH Annu Meet Abstr 2011; 118: 109.
-
(2011)
ASH Annu Meet Abstr
, vol.118
, pp. 109
-
-
Cortes, J.E.1
Kim, D.-W.2
Pinilla-Ibarz, J.3
Le Coutre, P.D.4
Chuah, C.5
Nicolini, F.E.6
-
16
-
-
80755185510
-
Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias
-
Nicolini FE, Basak GW, Soverini S, Martinelli G, Mauro MJ, Müller MC et al. Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias. Blood 2011; 118: 5697-5700.
-
(2011)
Blood
, vol.118
, pp. 5697-5700
-
-
Nicolini, F.E.1
Basak, G.W.2
Soverini, S.3
Martinelli, G.4
Mauro, M.J.5
Müller, M.C.6
-
17
-
-
33747156914
-
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure
-
Jabbour E, Cortes J, Kantarjian HM, Giralt S, Jones D, Jones R et al. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure. Blood 2006; 108: 1421-1423.
-
(2006)
Blood
, vol.108
, pp. 1421-1423
-
-
Jabbour, E.1
Cortes, J.2
Kantarjian, H.M.3
Giralt, S.4
Jones, D.5
Jones, R.6
-
18
-
-
84909982783
-
Imatinib mesylate versus allogeneic HSCT for patients with chronic myelogenous leukemia in accelerated phase: A single center experience in China after a 9-year follow-up
-
Jiang Q, Xu L-P, Liu D-H, Liu K, Chen S-S, Jiang B et al. Imatinib mesylate versus allogeneic HSCT for patients with chronic myelogenous leukemia in accelerated phase: a single center experience in China after a 9-year follow-up. ASH Annu Meet Abstr 2010; 116: 2347.
-
(2010)
ASH Annu Meet Abstr
, vol.116
, pp. 2347
-
-
Jiang, Q.1
Xu, L.-P.2
Liu, D.-H.3
Liu, K.4
Chen, S.-S.5
Jiang, B.6
-
19
-
-
84891490008
-
Allogeneic stem cell transplantation for CML in second chronic phase after blast crisis in the tyrosine kinase inhibitor era
-
Ahmed S, Chiattone A, Jones R, Sphall EJ, Farhan S, Rondon G et al. Allogeneic stem cell transplantation for CML in second chronic phase after blast crisis in the tyrosine kinase inhibitor era. ASH Annu Meet Abstr 2011; 118: 2039-.
-
(2011)
ASH Annu Meet Abstr
, vol.118
, pp. 2039
-
-
Ahmed, S.1
Chiattone, A.2
Jones, R.3
Sphall, E.J.4
Farhan, S.5
Rondon, G.6
-
20
-
-
50649111595
-
HLA-mismatched/ haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: Improved outcomes in patients in accelerated phase and blast crisis phase
-
Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H et al. HLA-mismatched/ haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Ann Med 2008; 40: 444-455.
-
(2008)
Ann Med
, vol.40
, pp. 444-455
-
-
Xiao-Jun, H.1
Lan-Ping, X.2
Kai-Yan, L.3
Dai-Hong, L.4
Huan, C.5
Wei, H.6
-
21
-
-
84909964922
-
Safety and efficacy of haploidentical stem cell transplantation for advanced chronic myeloid leukemia
-
Adekola K, di Stasi A, Ferro R, Ahmed S, de Lima MJG, Oran B et al. Safety and efficacy of haploidentical stem cell transplantation for advanced chronic myeloid leukemia. Biol Blood Marrow Transplant 2014; 20: S213-S214.
-
(2014)
Biol Blood Marrow Transplant
, vol.20
, pp. S213-S214
-
-
Adekola, K.1
Di Stasi, A.2
Ferro, R.3
Ahmed, S.4
De Lima, M.J.G.5
Oran, B.6
-
22
-
-
84872970465
-
Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management
-
Tefferi A. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol 2013; 88: 141-150.
-
(2013)
Am J Hematol
, vol.88
, pp. 141-150
-
-
Tefferi, A.1
-
23
-
-
84865174824
-
Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors
-
Gupta V, Hari P, Hoffman R. Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors. Blood 2012; 120: 1367-1379.
-
(2012)
Blood
, vol.120
, pp. 1367-1379
-
-
Gupta, V.1
Hari, P.2
Hoffman, R.3
-
24
-
-
33846028528
-
Philadelphia chromosome-negative myeloproliferative disorders: Biology and treatment
-
Hoffman R, Prchal JT, Samuelson S, Ciurea SO, Rondelli D. Philadelphia chromosome-negative myeloproliferative disorders: biology and treatment. Biol Blood Marrow Transplant 2007; 13 (Suppl 1):64-72.
-
(2007)
Biol Blood Marrow Transplant
, vol.13
, pp. 64-72
-
-
Hoffman, R.1
Prchal, J.T.2
Samuelson, S.3
Ciurea, S.O.4
Rondelli, D.5
-
25
-
-
84875879764
-
Ruxolitinib: An oral Janus kinase 1 and Janus kinase. 2. Inhibitor in the management of myelofibrosis
-
Verstovsek S. Ruxolitinib: an oral Janus kinase. 1. and Janus kinase. 2. inhibitor in the management of myelofibrosis. Postgrad Med 2013; 125: 128-135.
-
(2013)
Postgrad Med
, vol.125
, pp. 128-135
-
-
Verstovsek, S.1
-
26
-
-
84858668231
-
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation
-
Scott BL, Gooley TA, Sorror ML, Rezvani AR, Linenberger ML, Grim J et al. The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation. Blood 2012; 119: 2657-2664.
-
(2012)
Blood
, vol.119
, pp. 2657-2664
-
-
Scott, B.L.1
Gooley, T.A.2
Sorror, M.L.3
Rezvani, A.R.4
Linenberger, M.L.5
Grim, J.6
-
27
-
-
79952087335
-
DIPSS plus: A refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status
-
Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol 2011; 29: 392-397.
-
(2011)
J Clin Oncol
, vol.29
, pp. 392-397
-
-
Gangat, N.1
Caramazza, D.2
Vaidya, R.3
George, G.4
Begna, K.5
Schwager, S.6
-
28
-
-
79953711716
-
How i treat myelofibrosis
-
Tefferi A. How I treat myelofibrosis. Blood 2011; 117: 3494-3504.
-
(2011)
Blood
, vol.117
, pp. 3494-3504
-
-
Tefferi, A.1
-
29
-
-
77949401992
-
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: A predictive transplant score based on transfusion requirement, spleen size and donor type
-
Bacigalupo A, Soraru M, Dominietto A, Pozzi S, Geroldi S, Van Lint MT et al. Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplant 2010; 45: 458-463.
-
(2010)
Bone Marrow Transplant
, vol.45
, pp. 458-463
-
-
Bacigalupo, A.1
Soraru, M.2
Dominietto, A.3
Pozzi, S.4
Geroldi, S.5
Van Lint, M.T.6
-
30
-
-
84859411901
-
Management of myelofibrosis
-
Vannucchi AM. Management of myelofibrosis. Hematology 2011; 2011: 222-230.
-
(2011)
Hematology
, vol.2011
, pp. 222-230
-
-
Vannucchi, A.M.1
-
31
-
-
78149465870
-
The role of allogeneic SCT in primary myelofibrosis: A British Society for Blood and Marrow Transplantation study
-
Stewart WA, Pearce R, Kirkland KE, Bloor A, Thomson K, Apperley J et al. The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study. Bone Marrow Transplant 2010; 45: 1587-1593.
-
(2010)
Bone Marrow Transplant
, vol.45
, pp. 1587-1593
-
-
Stewart, W.A.1
Pearce, R.2
Kirkland, K.E.3
Bloor, A.4
Thomson, K.5
Apperley, J.6
-
32
-
-
75749125700
-
Outcome of transplantation for myelofibrosis
-
Ballen KK, Shrestha S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ et al. Outcome of transplantation for myelofibrosis. Biol Blood Marrow Transplant 2010; 16: 358-367.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 358-367
-
-
Ballen, K.K.1
Shrestha, S.2
Sobocinski, K.A.3
Zhang, M.J.4
Bashey, A.5
Bolwell, B.J.6
-
33
-
-
73949084969
-
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: A prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
-
Kroger N, Holler E, Kobbe G, Bornhauser M, Schwerdtfeger R, Baurmann H et al. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood 2009; 114: 5264-5270.
-
(2009)
Blood
, vol.114
, pp. 5264-5270
-
-
Kroger, N.1
Holler, E.2
Kobbe, G.3
Bornhauser, M.4
Schwerdtfeger, R.5
Baurmann, H.6
-
34
-
-
84865184403
-
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic hematopoietic stem cell transplantation conditioned with fludarabine/melphalan in patients with myelofibrosis
-
Rondelli D, Goldberg JD, Marchioli R, Isola L, Shore TB, Prchal JT et al. Results of Phase II Clinical Trial MPD-RC 101: allogeneic hematopoietic stem cell transplantation conditioned with fludarabine/melphalan in patients with myelofibrosis. ASH Annu Meet Abstr 2011; 118: 1750.
-
(2011)
ASH Annu Meet Abstr
, vol.118
, pp. 1750
-
-
Rondelli, D.1
Goldberg, J.D.2
Marchioli, R.3
Isola, L.4
Shore, T.B.5
Prchal, J.T.6
-
35
-
-
33846880278
-
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis
-
Kröger N, Badbaran A, Holler E, Hahn J, Kobbe G, Bornhäuser M et al. Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis. Blood 2007; 109: 1316-1321.
-
(2007)
Blood
, vol.109
, pp. 1316-1321
-
-
Kröger, N.1
Badbaran, A.2
Holler, E.3
Hahn, J.4
Kobbe, G.5
Bornhäuser, M.6
-
36
-
-
77956302639
-
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis
-
Alchalby H, Badbaran A, Zabelina T, Kobbe G, Hahn J, Wolff D et al. Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis. Blood 2010; 116: 3572-3581.
-
(2010)
Blood
, vol.116
, pp. 3572-3581
-
-
Alchalby, H.1
Badbaran, A.2
Zabelina, T.3
Kobbe, G.4
Hahn, J.5
Wolff, D.6
-
37
-
-
84909942848
-
Allogeneic transplantation for myelofibrosis: B enefit of dose intensity
-
Popat UR, Bassett R, Chen J, Alousi AM, Anderlini P,Ciurea SO,et al. Allogeneic transplantation for myelofibrosis: b enefit of dose intensity. ASCO Meet Abstr 2013; 31 (Suppl):7011.
-
(2013)
ASCO Meet Abstr
, vol.31
, pp. 7011
-
-
Popat, U.R.1
Bassett, R.2
Chen, J.3
Alousi, A.M.4
Anderlini, P.5
Ciurea, S.O.6
-
38
-
-
12844284481
-
Leukemic transformation in myelofibrosis with myeloid metaplasia: A single-institution experience with
-
Mesa RA, Li CY, Ketterling RP, Schroeder GS, Knudson RA, Tefferi A. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with. 91. cases. Blood 2005; 105: 973-977.
-
(2005)
91. Cases. Blood
, vol.105
, pp. 973-977
-
-
Mesa, R.A.1
Li, C.Y.2
Ketterling, R.P.3
Schroeder, G.S.4
Knudson, R.A.5
Tefferi, A.6
-
39
-
-
77649340207
-
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation
-
Ciurea SO, de Lima M, Giralt S, Saliba R, Bueso-Ramos C, Andersson BS et al. Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation. Biol Blood Marrow Transplant 2010; 16: 555-559.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 555-559
-
-
Ciurea, S.O.1
De Lima, M.2
Giralt, S.3
Saliba, R.4
Bueso-Ramos, C.5
Andersson, B.S.6
-
40
-
-
84878225843
-
Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms
-
Kennedy JA, Atenafu EG, Messner HA, Craddock KJ, Brandwein JM, Lipton JH et al. Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms. Blood 2013; 121: 2725-2733.
-
(2013)
Blood
, vol.121
, pp. 2725-2733
-
-
Kennedy, J.A.1
Atenafu, E.G.2
Messner, H.A.3
Craddock, K.J.4
Brandwein, J.M.5
Lipton, J.H.6
-
41
-
-
79953074952
-
Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia
-
Bacher U, Haferlach T, Schnittger S, Kreipe H, Kroger N. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia. Br J Haematol 2011; 153: 149-167.
-
(2011)
Br J Haematol
, vol.153
, pp. 149-167
-
-
Bacher, U.1
Haferlach, T.2
Schnittger, S.3
Kreipe, H.4
Kroger, N.5
-
42
-
-
84859452133
-
Current status of allogeneic HST for chronic myelomonocytic leukemia
-
Cheng H, Kirtani VG, Gergis U. Current status of allogeneic HST for chronic myelomonocytic leukemia. Bone Marrow Transplant 2012; 47: 535-541.
-
(2012)
Bone Marrow Transplant
, vol.47
, pp. 535-541
-
-
Cheng, H.1
Kirtani, V.G.2
Gergis, U.3
-
43
-
-
41849134682
-
Diagnosis and management of chronic myelomonocytic leukemia
-
Onida F, Beran M. Diagnosis and management of chronic myelomonocytic leukemia. Curr Hematol Malign Rep 2008; 3: 31-36.
-
(2008)
Curr Hematol Malign Rep
, vol.3
, pp. 31-36
-
-
Onida, F.1
Beran, M.2
-
44
-
-
84861349850
-
Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management
-
Parikh SA, Tefferi A. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012; 87: 610-619.
-
(2012)
Am J Hematol
, vol.87
, pp. 610-619
-
-
Parikh, S.A.1
Tefferi, A.2
-
45
-
-
79952349006
-
Cytogenetic risk stratification in chronic myelomonocytic leukemia
-
Such E, Cervera J, Costa D, Sole F, Vallespi T, Luno E et al. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica 2011; 96: 375-383.
-
(2011)
Haematologica
, vol.96
, pp. 375-383
-
-
Such, E.1
Cervera, J.2
Costa, D.3
Sole, F.4
Vallespi, T.5
Luno, E.6
-
46
-
-
0036464647
-
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients
-
Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002; 99: 840-849.
-
(2002)
Blood
, vol.99
, pp. 840-849
-
-
Onida, F.1
Kantarjian, H.M.2
Smith, T.L.3
Ball, G.4
Keating, M.J.5
Estey, E.H.6
-
47
-
-
0036067374
-
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Multicenter Study]
-
Kroger N, Zabelina T, Guardiola P, Runde V, Sierra J, Van Biezen A et al. Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Multicenter Study]. Br J Haematol 2002; 118: 67-73
-
(2002)
Br J Haematol
, vol.118
, pp. 67-73
-
-
Kroger, N.1
Zabelina, T.2
Guardiola, P.3
Runde, V.4
Sierra, J.5
Van Biezen, A.6
-
48
-
-
77957949202
-
-
Krishnamurthy P, Lim ZY, Nagi W, Kenyon M, Mijovic A, Ireland R et al. Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience. Bone Marrow Transplant 2010; 45: 1502-1507.
-
(2010)
Allogeneic Haematopoietic SCT for Chronic Myelomonocytic Leukaemia: A Single-centre Experience. Bone Marrow Transplant
, vol.45
, pp. 1502-1507
-
-
Krishnamurthy, P.1
Lim, Z.Y.2
Nagi, W.3
Kenyon, M.4
Mijovic, A.5
Ireland, R.6
-
49
-
-
84894282273
-
Allogeneic stem cell transplantation in patients with chronic myelomonocytic leukaemia: The impact of WHO classification and of the conditioning regimen on the transplantation outcome
-
Symeonidis A, van Biezen A, Mufti G, Finke J, Beelen D, Bornhauser M et al. Allogeneic stem cell transplantation in patients with chronic myelomonocytic leukaemia: the impact of WHO classification and of the conditioning regimen on the transplantation outcome. Bone Marrow Transplant 2010; 45 (Suppl 2): S241.
-
(2010)
Bone Marrow Transplant
, vol.45
, pp. S241
-
-
Symeonidis, A.1
Van Biezen, A.2
Mufti, G.3
Finke, J.4
Beelen, D.5
Bornhauser, M.6
-
50
-
-
0033887739
-
Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation
-
Zang DY, Deeg HJ, Gooley T, Anderson JE, Anasetti C, Sanders J et al. Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation. Br J Haematol 2000; 110: 217-222.
-
(2000)
Br J Haematol
, vol.110
, pp. 217-222
-
-
Zang, D.Y.1
Deeg, H.J.2
Gooley, T.3
Anderson, J.E.4
Anasetti, C.5
Sanders, J.6
-
51
-
-
79956054105
-
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: Relapsefree survival is determined by karyotype and comorbidities
-
Eissa H, Gooley TA, Sorror ML, Nguyen F, Scott BL, Doney K et al. Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapsefree survival is determined by karyotype and comorbidities. Biol Blood Marrow Transplant 2011; 17: 908-915.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, pp. 908-915
-
-
Eissa, H.1
Gooley, T.A.2
Sorror, M.L.3
Nguyen, F.4
Scott, B.L.5
Doney, K.6
-
52
-
-
84909942843
-
Outcomes in patients with chronic myelomonocytic leukemia: Analysis of 279 patients
-
Borthakur G, Beran M, Liu J, Verma D, Dong XQ, Rondon G et al. Outcomes in patients with chronic myelomonocytic leukemia: analysis of 279 patients. ASH Annu Meet Abstr 2008; 112: 3235.
-
(2008)
ASH Annu Meet Abstr
, vol.112
, pp. 3235
-
-
Borthakur, G.1
Beran, M.2
Liu, J.3
Verma, D.4
Dong, X.Q.5
Rondon, G.6
-
53
-
-
20144363192
-
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [article]
-
Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas M, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [article]. Lancet 2005; 365: 1054-1061.
-
(2005)
Lancet
, vol.365
, pp. 1054-1061
-
-
Baxter, E.J.1
Scott, L.M.2
Campbell, P.J.3
East, C.4
Fourouclas, M.5
Swanton, S.6
-
54
-
-
0035120673
-
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia
-
Jurado M, Deeg H, Gooley T, Anasetti C, Chauncey T, Flowers M et al. Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia. Br J Haematol 2001; 112: 392-396.
-
(2001)
Br J Haematol
, vol.112
, pp. 392-396
-
-
Jurado, M.1
Deeg, H.2
Gooley, T.3
Anasetti, C.4
Chauncey, T.5
Flowers, M.6
-
55
-
-
0036290026
-
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation
-
Platzbecker U, Gooley T, Anasetti C, Appelbaum FR, Clurman B, Doney K, et al. Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation. Leuk Lymphoma 2002; 43: 1409-1414.
-
(2002)
Leuk Lymphoma
, vol.43
, pp. 1409-1414
-
-
Platzbecker, U.1
Gooley, T.2
Anasetti, C.3
Appelbaum, F.R.4
Clurman, B.5
Doney, K.6
-
56
-
-
33847083481
-
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia
-
Kerbauy DM, Gooley TA, Sale GE, Flowers ME, Doney KC, Georges GE et al. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biol Blood Marrow Transplant 2007; 13: 355-365.
-
(2007)
Biol Blood Marrow Transplant
, vol.13
, pp. 355-365
-
-
Kerbauy, D.M.1
Gooley, T.A.2
Sale, G.E.3
Flowers, M.E.4
Doney, K.C.5
Georges, G.E.6
-
57
-
-
84865198731
-
Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia
-
Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M et al. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biol Blood Marrow Transplant 2012; 18: 1446-1454.
-
(2012)
Biol Blood Marrow Transplant
, vol.18
, pp. 1446-1454
-
-
Ballen, K.K.1
Woolfrey, A.E.2
Zhu, X.3
Ahn, K.W.4
Wirk, B.5
Arora, M.6
|